Log in to save to my catalogue

In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy

In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a45bab9f0c7c40549d8a8e904504777f

In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy

About this item

Full title

In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2024-11, Vol.15 (1), p.10218-15, Article 10218

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Immune checkpoint blockade (ICB) therapy, while promising for cancer treatment, faces challenges like unexpected side effects and limited objective responses. Here, we develop an in vivo gene-editing strategy for improving ICB cancer therapy in a lastingly effective manner. The approach uses a conductive hydrogel-based electroporation system to ena...

Alternative Titles

Full title

In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a45bab9f0c7c40549d8a8e904504777f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a45bab9f0c7c40549d8a8e904504777f

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-54292-0

How to access this item